Literature DB >> 19648294

p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR.

Faraz Farooq1, Sylvia Balabanian, Xuejun Liu, Martin Holcik, Alex MacKenzie.   

Abstract

Spinal muscle atrophy (SMA) is an autosomal recessive neurodegenerative disease which is characterized by the loss of alpha motor neurons resulting in progressive muscle atrophy. Reduced amount of functional survival motor neuron (SMN) protein due to mutations or deletion in the SMN1 gene is the cause of SMA. A potential treatment strategy for SMA is to upregulate levels of SMN protein originating from the SMN2 gene compensating in part for the absence of functional SMN1 gene. Although there exists a sizeable literature on SMN2 inducing compounds, there is comparatively less known about the signaling pathways which modulate SMN levels. Here, we report a significant induction in SMN mRNA and protein following p38 activation by Anisomycin. We demonstrate that Anisomycin activation of p38 causes a rapid cytoplasmic accumulation of HuR, a RNA binding protein which binds to and stabilizes the AU-rich element within the SMN transcript. The stabilization of SMN mRNA, rather than transcriptional induction results in an increase in SMN protein. Our demonstration of SMN protein regulation through the p38 pathway and the role of HuR in this modulation may help in the identification and characterization of p38 pathway activators as potential therapeutic compounds for the treatment of SMA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648294     DOI: 10.1093/hmg/ddp352

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

Review 1.  Controlling gene expression in response to stress.

Authors:  Eulàlia de Nadal; Gustav Ammerer; Francesc Posas
Journal:  Nat Rev Genet       Date:  2011-11-03       Impact factor: 53.242

2.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

Review 3.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

Review 4.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation.

Authors:  Kym M Boycott; Megan R Vanstone; Dennis E Bulman; Alex E MacKenzie
Journal:  Nat Rev Genet       Date:  2013-09-03       Impact factor: 53.242

Review 5.  Multilayered control of gene expression by stress-activated protein kinases.

Authors:  Eulàlia de Nadal; Francesc Posas
Journal:  EMBO J       Date:  2009-11-26       Impact factor: 11.598

Review 6.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

7.  Small molecule screen reveals regulation of survival motor neuron protein abundance by Ras proteins.

Authors:  Reka R Letso; Andras J Bauer; Mitchell R Lunn; Wan Seok Yang; Brent R Stockwell
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

Review 8.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

9.  U1A regulates 3' processing of the survival motor neuron mRNA.

Authors:  Eileen Workman; Alex Veith; Daniel J Battle
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 10.  Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.

Authors:  Khalid S A Khabar
Journal:  Cell Mol Life Sci       Date:  2010-05-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.